标题
Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience
作者
关键词
-
出版物
Journal of Clinical Lipidology
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-12-08
DOI
10.1016/j.jacl.2022.12.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sex differences in low-density lipoprotein cholesterol reduction with PCSK9 inhibitors in real world patients
- (2022) Alberto Cordero et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2021) Glen J. Pearson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Efficacy of PCSK9 inhibitors in the treatment of heterozygous familial hypercholesterolemia: A clinical practice experience
- (2021) Rodrigo Alonso et al. Journal of Clinical Lipidology
- Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction
- (2021) Calvin L. Colvin et al. Journal of Clinical Lipidology
- LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
- (2021) Christos V. Rizos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
- (2020) Jacqueline S. Dron et al. BMC Medical Genomics
- Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care
- (2020) Sujana Balla et al. Current Atherosclerosis Reports
- Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia
- (2020) Candace L. Jackson et al. Journal of Clinical Lipidology
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid Lowering Therapy and Circulating PCSK9 Concentration
- (2017) Tsuyoshi Nozue Journal of Atherosclerosis and Thrombosis
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia
- (2016) Leopoldo Perez de Isla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans
- (2015) T.C. Ooi et al. CLINICA CHIMICA ACTA
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
- (2015) Sue Richards et al. GENETICS IN MEDICINE
- PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice
- (2015) Anna Roubtsova et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein (a): impact by ethnicity and environmental and medical conditions
- (2015) Byambaa Enkhmaa et al. JOURNAL OF LIPID RESEARCH
- The Effects of Estrogen on Serum Level and Hepatocyte Expression of PCSK9
- (2015) Wen Guo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol
- (2014) Moumita Ghosh et al. JOURNAL OF LIPID RESEARCH
- Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
- (2009) Stephen J. Nicholls et al. AMERICAN JOURNAL OF CARDIOLOGY
- Genetic and Metabolic Determinants of Plasma PCSK9 Levels
- (2009) Susan G. Lakoski et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More